Connect with us

Technology

Cameron James: the 10 funniest things I have ever seen (on the internet) | Culture

I’ve missed people. Thanks to something called Covid-19 (look it up), I’ve been around other human beings less and less over the past couple of years. And I’ve missed you! I’ve missed overhearing couples bicker on the train, and watching Insta girls’ photoshoots get ruined by their dog, and seeing cocky business guys with Bluetooth headsets trip over on the footpath.

And most of all I’ve missed my favourite brand of real-world comedy: the moment when absurdity meets reality; the strange brew of “absolutely 100% real” and “that has to be fake”.

Luckily for me, the internet has a bunch of this sorta stuff on it, so it turns out I didn’t need real life at all! Here’s 10 of my faves. There’s some magic in these clips that says something powerful about humanity striving for connection. Or maybe it’s just funny to see people screw up. You be the judge.

1. Philomena Cunk

This is exactly what I’m on about. Diane Morgan (genius character comedian) embodies her dense and rude journalist character Philomena Cunk so fully and completely that when real experts sit opposite her in an interview setting they are forced to react. Will they mock her? Or try to help her? It’s watching real people have to decide in the moment whether to be empathetic to a dumb asshole. I love it, and I love her, but we’re both in long-term relationships plus she’s never heard of me so it probably wouldn’t work out.

2. The high five

You either like Jackass or you don’t. I won’t waste valuable words trying to convert the second group. All I’ll say is this clip is a real life Looney Tunes of harmless fun, and I wish it went for another 30 minutes.

3. Oh, hello

Remember when the internet acted all shocked and surprised when John Mulaney split with his wife, then went on a bender, then started dating a celebrity, then got that celebrity pregnant? I wasn’t surprised. Because the dark, manic side of Mulaney has always been right in front of us in his character of George from Oh, Hello. This is a 90-minute improvised conversation where you get to watch Mulaney’s mind work in real time in response to unrehearsed questions from the moderator and the crowd, and – guess what – he’s evil as hell.

4. Rude talking car

Allow Instagram content?

This article includes content provided by Instagram. We ask for your permission before anything is loaded, as they may be using cookies and other technologies. To view this content, click ‘Allow and continue’.

Comedians and married couple Brendon Walsh and Amanda Conrad host the podcast the World Record Podcast where they spend 99% of their time prank-calling local businesses and testing the patience of middle management. It’s addictive listening. These two are artists at keeping people on the hook, and guiding them towards snapping. This one features a soulful performance from Amanda as a lady whose car AI keeps insulting her.

5. Nathan Fielder and John Wilson

These dudes made two of my favourite shows of the last decade. Nathan For You and How To with John Wilson were flipsides of the same coin, capturing real human beings in moments of their most absurd. This clip begins as a genuine behind-the-scenes video, but soon morphs into performance art from two guys who love cringe as much as I do.

6. David S Pumpkins

OK this has nothing to do with my theme of “absurdity v reality”, but it’s a go-to sketch I watch when I need a cheer-up. Plus there’s something incredibly surreal in seeing acclaimed actor Tom Hanks commit so fully to the most outrageous SNL character piece since the days of MacGruber. Yeah, now we’re back on theme! It’s Tom Hanks (Oscar winner) doing something wacky! That kinda fits.

7. This Country

The Office made its debut in 2001 and everyone tried to copy its mockumentary format, but none ever really lived up to it. Until This Country. Daisy May Cooper and Charlie Cooper are a sibling duo from regional Britain who’ve made a comedy about class that’s the closest thing I’ve seen to being a real documentary – mostly because the rest of the cast is made up of the real-life locals of their home town.

8. Xtremers

Kyle Mooney is now on SNL, but in the early internet days when he first started posting on YouTube, I had no idea who this guy was. YouTube sketch was so new and unformed that I even thought this guy might be a real interviewer for a few seconds. His style – of being nervous to talk to even the most ordinary of people – instantly makes forces his subjects to step up and take charge of the interview. So funnnyyyyyyyyyy.

9. Who Is America?

This was Sacha Baron Cohen’s big comeback to pranking people on TV and I can’t explain to you how excited me and all my comedian friends were. This prank on former Republican politician Jason Spencer (he was forced to resign after what he does in this clip) was a highlight. How on Earth does he get people to do this? And how do they believe the insane prosthetic job?

10. Kate Berlant and John Early

The idea of getting the highly coveted standup comedy spot on The Tonight Show, and wasting it with a semi-scripted meltdown is so inherently funny to me. I love to imagine regular Americans at home watching it with furrowed brows, not realising it’s a bit.

  • Cameron James is a comedian and podcaster. You can follow him on Instagram, listen to his podcasts, and see his new stand up show Electric Dreams live around the country in 2022



Source link

Current

Congratulations, Privacy Just Took A Great Leap Out the Window!

Your Data Is Being Used Without Your Permission And Knowledge

The Voice Of EU | In the heart of technological innovation, the collision between intellectual property rights and the development of cutting-edge AI technologies has sparked a significant legal battle. The New York Times has taken legal action against OpenAI and Microsoft, filing a lawsuit in Manhattan federal court. This legal maneuver aims to address concerns surrounding the unauthorized use of the Times’ content for the training of AI models, alleging copyright infringements that could potentially result in billions of dollars in damages.

READ: HOW YOUR DATA IS BEING USED TO TRAIN A.I.

This legal tussle underlines the escalating tension between technological advancements and the protection of intellectual property. The crux of the lawsuit revolves around OpenAI and Microsoft allegedly utilizing the Times’ proprietary content to advance their own AI technology, directly competing with the publication’s services. The lawsuit suggests that this unauthorized utilization threatens the Times’ ability to offer its distinctive service and impacts its AI innovation, creating a competitive landscape that challenges the publication’s proprietary content.

Amidst the growing digital landscape, media organizations like the Times are confronting a myriad of challenges. The migration of readers to online platforms has significantly impacted traditional media, and the advent of artificial intelligence technology has added another layer of complexity. The legal dispute brings to the forefront the contentious practice of AI companies scraping copyrighted information from online sources, including articles from media organizations, to train their generative AI chatbots. This strategy has attracted substantial investments, rapidly transforming the AI landscape.

Exhibit presented by the New York Times’ legal team of ChatGPT replicating a article after being prompted

The lawsuit highlights instances where OpenAI’s technology, specifically GPT-4, replicated significant portions of Times articles, including in-depth investigative reports. These outputs, alleged by the Times to contain verbatim excerpts from their content, raise concerns about the ethical and legal boundaries of using copyrighted material for AI model training without proper authorization or compensation.

The legal action taken by the Times follows attempts to engage in discussions with Microsoft and OpenAI, aiming to address concerns about the use of its intellectual property. Despite these efforts, negotiations failed to reach a resolution that would ensure fair compensation for the use of the Times’ content while promoting responsible AI development that benefits society.

In the midst of this legal battle, the broader questions surrounding the responsible and ethical utilization of copyrighted material in advancing technological innovations come to the forefront.

The dispute between the Times, OpenAI, and Microsoft serves as a significant case study in navigating the intricate intersection of technological progress and safeguarding intellectual property rights in the digital age.


Continue Reading

Culture

Conflicted History: ‘Oppenheimer’ And Its Impact On Los Alamos And New Mexico Downwinders

‘Oppenheimer’ And Its Impact On Los Alamos And New Mexico Downwinders

The Voice Of EU | In the highly anticipated blockbuster movie, “Oppenheimer,” the life of J. Robert Oppenheimer, the man behind the first atomic bomb, is portrayed as a riveting tale of triumph and tragedy.

As the film takes center stage, it also brings to light the often-overlooked impacts on a community living downwind from the top-secret Manhattan Project testing site in southern New Mexico.

A Forgotten Legacy

While the film industry and critics praise “Oppenheimer,” a sense of frustration prevails among the residents of New Mexico’s Tularosa Basin, who continue to grapple with the consequences of the Manhattan Project. Tina Cordova, a cancer survivor and founder of the Tularosa Basin Downwinders Consortium, expresses their feelings, stating, “They invaded our lives and our lands and then they left,” referring to the scientists and military personnel who conducted secret experiments over 200 miles away from their community.

The Consortium, alongside organizations like the Union of Concerned Scientists, has been striving to raise awareness about the impact of the Manhattan Project on New Mexico’s population. Advocates emphasize the necessity of acknowledging the human cost of the Trinity Test, the first atomic blast, and other nuclear weapons activities that have affected countless lives in the state.

The Ongoing Struggle for Recognition

As film enthusiasts celebrate the drama and brilliance of “Oppenheimer,” New Mexico downwinders feel overlooked by both the U.S. government and movie producers. The federal government’s compensation program for radiation exposure still does not include these affected individuals. The government’s selection of the remote and flat Trinity Test Site, without warning residents in the surrounding areas, further added to the controversy.

Living off the land, the rural population in the Tularosa Basin had no idea that the fine ash settling on their homes and fields was a result of the world’s first atomic explosion.

The government initially attempted to cover up the incident, attributing the bright light and rumble to an explosion at a munitions dump. It was only after the U.S. dropped atomic bombs on Japan weeks later that New Mexico residents realized the magnitude of what they had witnessed.

Tracing the Fallout

According to the Manhattan Project National Historical Park, large amounts of radiation were released into the atmosphere during the Trinity Test, with fallout descending over a vast area. Some of the fallout reached as far as the Atlantic Ocean, but the greatest concentration settled approximately 30 miles from the test site.

Now I Am Become Death, the Destroyer of Worlds.

J. Robert Oppenheimer

The consequences of this catastrophic event have affected generations of New Mexicans, who still await recognition and justice for the harm caused by nuclear weapons.

A Tale of Contrasts: Los Alamos and the Legacy of Oppenheimer

As the film’s spotlight shines on the life of J. Robert Oppenheimer, a contrasting narrative unfolds in Los Alamos, more than 200 miles north of the Tularosa Basin. Los Alamos stands as a symbol of Oppenheimer’s legacy, housing one of the nation’s premier national laboratories and boasting the highest percentage of people with doctorate degrees in the U.S.

Oppenheimer’s influence is evident throughout Los Alamos, with a street bearing his name and an IPA named in his honor at a local brewery. The city embraces its scientific legacy, showcasing his handwritten notes and ID card in a museum exhibit. Los Alamos National Laboratory employees played a significant role in the film, contributing as extras and engaging in enlightening discussions during breaks.

The “Oppenheimer” Movie

Director Christopher Nolan’s perspective on the Trinity Test and its profound impact is evident in his approach to “Oppenheimer.” He has described the event as an extraordinary moment in human history and expressed his desire to immerse the audience in the pivotal moment when the button was pushed. Nolan’s dedication to bringing historical accuracy and emotional depth to the screen is evident as he draws inspiration from Kai Bird and Martin J. Sherwin’s Pulitzer Prize-winning book, “American Prometheus: The Triumph and Tragedy of J. Robert Oppenheimer.

For Nolan, Oppenheimer’s story is a potent blend of dreams and nightmares, capturing the complexity and consequences of the Manhattan Project. As the film reaches global audiences, it also offers a unique opportunity to raise awareness about the downwinders in New Mexico, whose lives were forever altered by the legacy of nuclear weapons testing.

The Oppenheimer Festival and Beyond

Los Alamos is determined to use the Oppenheimer Festival as an opportunity to educate visitors about the true stories behind the film’s events. The county’s “Project Oppenheimer” initiative, launched in early 2023, encompasses forums, documentaries, art installations, and exhibits that delve into the scientific contributions of the laboratory and the social implications of the Manhattan Project.

A special area during the festival will facilitate discussions about the movie, fostering a deeper understanding of the community’s history. The county aims to continue revisiting and discussing the legacy of the Manhattan Project, ensuring that the impact of this pivotal moment in history is never forgotten.

As “Oppenheimer” takes audiences on an emotional journey, it serves as a reminder that every historical event carries with it complex and multifaceted implications. The movie may celebrate the scientific achievements of the past, but it also illuminates the urgent need to recognize and address the human cost that persists to this day.


We Can’t Thank You Enough For Your Support!

— By Team VoiceOfEU.com

— For Info.: info@VoiceOfEU.com

— Anonymous Submissions: press@VoiceOfEU.com


Continue Reading

Current

GSK’s Mosquirix Is Revolutionizing The Fight Against Malaria

GSK’s Mosquirix And The Fight Against Malaria

Over the past three years, the global focus has primarily been on the Covid-19 pandemic, diverting attention and resources away from other infectious diseases that disproportionately affect vulnerable populations in the Global South. Among these diseases, malaria continues to be a pressing public health concern, claiming the lives of hundreds of thousands of people each year, especially children in Sub-Saharan Africa. While significant progress has been made in preventing and treating malaria, innovative solutions are needed to combat this deadly disease.

Advancements in Malaria Prevention:

Researchers have made remarkable progress in both prevention and treatment strategies for malaria. The World Health Organization’s recommendation of dual-ingredient insecticide-treated bed nets in March 2023 marks a significant milestone in preventing malaria transmission by Anopheles mosquitoes. These nets, including those with more lethal insecticide combinations and those disrupting mosquito growth, are key tools in malaria prevention efforts.

LEARN MORE: ALL ABOUT HEALTHCARE

The Importance of Cost-Effective Antimalarial Medicines:

Cost-effective antimalarial medicines play a crucial role in combating malaria. In 2021, approximately 45 million children between the ages of three months and five years received seasonal malaria chemoprevention, which involved monthly doses of therapeutic drugs at a cost of less than $4 per person. While this approach has shown promising results, the development of a groundbreaking vaccine brings renewed hope.

GSK’s Mosquirix (RTS,S) Vaccine:

GSK’s Mosquirix, also known as RTS,S, is an innovative vaccine that has the potential to transform the fight against malaria. This vaccine offers hope in preventing the disease, particularly among children in malaria-endemic regions. Although the current cost is relatively high, around $40 per child for the first year, it presents an essential step forward in malaria prevention efforts.

The Persistent Threat of Malaria:

Despite substantial investments of $26 billion to combat malaria in Sub-Saharan Africa, the number of cases has seen a slight increase between 2000 and 2019, although the number of deaths has decreased. This highlights the need for new prevention measures tailored to vulnerable populations, especially children. Taking inspiration from the Covid-19 pandemic, where monoclonal antibodies have demonstrated their potential, similar approaches could be explored in the fight against malaria.

The Potential of Monoclonal Antibodies:

Monoclonal antibodies, laboratory-made copies of immune system proteins, have shown immense potential in combating various diseases, including cancer and autoimmune disorders. Their remarkable selectivity and ability to target specific molecular markers make them an attractive option for preventive interventions. Researchers at the United States National Institutes of Health, led by Robert Seder, have identified two antibodies that target CSP-1, a protein used by the malaria parasite to invade liver cells. Clinical trials are currently underway in Mali and Kenya to assess their safety and efficacy, focusing on seasonal and year-round malaria transmission settings.

Game-Changing Potential:

Monoclonal antibodies have the potential to be a game-changer in malaria prevention, advancing the long-sought goal of eradication. The latest generation of antimalarial antibodies offers extended protection, with a single dose potentially safeguarding a child for at least three months, if not longer. Clinical trials will determine the extent and duration of this protection and guide future improvements to achieve a once-a-year injection.

Making Monoclonal Antibodies Accessible:

While monoclonal antibodies are often associated with high costs, efforts to increase their potency could significantly reduce expenses. It is estimated that an injection as small as one milliliter of the antibody drug being trialed in Mali and Kenya could protect children at a cost of only $5-10 per person. To ensure accessibility, it is crucial to engage national regulatory agencies and involve affected countries in the production of these biologics. While manufacturing antibodies is a complex and regulated process, investing in the necessary technology now would greatly benefit developing economies burdened by endemic malaria.

Addressing Disparities and Raising Awareness:

Currently, demand for monoclonal antibodies primarily comes from high-income countries, with Africa accounting for only 1% of global sales. This disparity underscores the importance of working with national regulatory agencies to address public health concerns and involve affected countries in the production and distribution of these life-saving biologics. Collaboration among government, academia, and industry is crucial to coordinate advocacy efforts and raise awareness about the potential of monoclonal antibodies in malaria prevention.

Preparing for Success:

While the deployment of the first generation of antimalarial antibodies is expected to occur no earlier than 2027, it is essential to start preparing for their potential success now. These antibodies hold tremendous promise as a powerful weapon in the fight against malaria, alongside bed nets, medicines, and emerging vaccines. Clinical trials will provide vital information on the extent of their efficacy, duration of protection, and dosage requirements. It is imperative to remain proactive and ensure that the necessary infrastructure and policies are in place to facilitate the widespread adoption of these breakthrough treatments.

Combining Science & Research:

As the world continues to battle the ongoing Covid-19 pandemic, it is crucial not to overlook the persistent threat of malaria, especially in regions heavily impacted by poverty. While significant progress has been made in malaria prevention and treatment, the development of innovative solutions like GSK’s Mosquirix vaccine and the potential of monoclonal antibodies offer renewed hope in the fight against this deadly disease. By harnessing the lessons learned from Covid-19 research and engaging in collaborative efforts, we can work towards a future where malaria is no longer a major public health concern. Together, we can strive for the eradication of malaria and ensure a healthier future for vulnerable populations worldwide.


By Laura Richardson | Independent Contributor “The Voice Of EU

Thank You For Your Support!

— Compiled by Team VoiceOfEU.com

— For More: info@VoiceOfEU.com

— Anonymous News Submissions: press@VoiceOfEU.com


Continue Reading

Trending

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates 
directly on your inbox.

You have Successfully Subscribed!